A genome-wide association study of a sustained pattern of antidepressant response

Journal of Psychiatric Research

Volumn 47, Issue 9, 2013, Pages 1157-1165

  Hunter, Aimee M ^a   Leuchter, Andrew F ^a   Power, Robert A ^b   Muthén, Bengt ^c   McGrath, Patrick J ^d   Lewis, Cathryn M ^b   Cook, Ian A ^a   Garriock, Holly A ^e,f   McGuffin, Peter ^b   Uher, Rudolf ^b,g   Hamilton, Steven P ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d New York State Psychiatric Institute ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antidepressant; Citalopram; D; GENDEP; Genetics; Growth mixture modeling; STAR

Indexed keywords

ACYL COENZYME A SYNTHETASE SHORT CHAIN FAMILY MEMBER 3; CHONDROITIN SULFATE; CHONDROITIN SULFATE N ACETYLGALACTOSAMINYLTRANSFERASE 1; CITALOPRAM; ESCITALOPRAM; LONG CHAIN FATTY ACID COENZYME A LIGASE; N ACETYLGALACTOSAMINYLTRANSFERASE; NORTRIPTYLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; LONG TERM POTENTIATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84880135878     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.05.002     Document Type: Article

References (41)

1. Altshuler D.M., Gibbs R.A., Peltonen L., Altshuler D.M., Gibbs R.A., Peltonen L., et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467:52-58.
2. Botta-Orfila T., Tolosa E., Gelpi E., Sànchez-Pla A., Martí M.J., Valldeoriola F., et al. Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease. Neurobiology of Disease 2012, 45:462-468.
3. Fava M., Rush A.J., Trivedi M.H., Nierenberg A.A., Thase M.E., Sackeim H.A., et al. Backgroundand rationale for the sequenced treatment alternatives to relievedepression (STAR*D) study. Psychiatric Clinics of North America 2003, 26:457-494.
4. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Research Reviews 2007, 54:1-18.
5. Garriock H.A., Kraft J.B., Shyn S.I., Peters E.J., Yokoyama J.S., Jenkins G.D., et al. Agenomewide association study of citalopram response in major depressive disorder. Biological Psychiatry 2010, 67:133-138.
6. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. The American Journal of Epidemiology 2002, 155:478-484.
7. Gueorguieva R., Mallinckrodt C., Krystal J.H. Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. Archives of General Psychiatry 2011, 68(12):1227-1237.
8. Hunter A.M., Muthén B.O., Cook I.A., Leuchter A.F. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of Psychiatric Research 2010, 44(2):90-98.
9. Kantor D.B., Chivatakarn O., Peer K.L., Oster S.F., Inatani M., Hansen M.J., et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44:961-975.
10. Kao C.F., Jia P., Zhao Z., Kuo P.H. Enriched pathways for major depressive disorder identified from a genome-wide association study. International Journal of Neuropsychopharmacology 2012, 15:1401-1411.
11. Keers R., Aitchison K.J. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics 2011, 11(1):101-125.
12. Kraft J.B., Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., McGrath P.J., et al. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biological Psychiatry 2007, 61:734-742.
13. Laje G., Perlis R.H., Rush A.J., McMahon F.J. Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatric Services 2009, 60:1446-1457.
14. Liu J.Z., McRae A.F., Nyholt D.R., Medland S.E., Wray N.R., Brown K.M., et al. Aversatile gene-based test for genome-wide association studies. American Journal of Human Genetics 2010, 87:139-145.
15. Malhotra A.K. The pharmacogenetics of depression: enter the GWAS. American Journal of Psychiatry 2010, 167:493-495.
16. Malhotra A.K., Zhang J.P., Lencz T. Pharmacogenetics in psychiatry: translating research into clinical practice. Molecular Psychiatry 2012, 17(8):760-769.
17. Muthén B., Asparouhov T. Growth mixture modeling: analysis with non-Gaussian random effects. Longitudinal data analysis 2009, 143-165. Chapman & Hall/CRC Press, Boca Raton, FL. G. Fitzmaurice, M. Davidian, G. Verbeke, G. Molenberghs (Eds.).
18. Muthén B., Asparouhov T., Hunter A.M., Leuchter A.F. Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychological Methods 2011, 16(1):17-33.
19. Muthén B., Brown H., Leuchter A.F., Hunter A.M. General approaches to analysis of course: applying growth mixture modeling to randomized trials of depression medication. Causality and psychopathology: finding the determinants of disorders andtheir cures 2008, p.159-p.178. American Psychiatric Publishing, Washington, D.C. P. Shrout, K. Keyes, K. Ornstein (Eds.).
20. Muthén B., Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics 1999, 55:463-469.
21. Onaga S.H., Takeuchi K., Watanabe Y., Komuta Y., Izumikawa T., Kitagawa H., et al. Neuroscience Research 2010, 68:e250.
22. Orlando C., Ster J., Gerber U., Fawcett J.W., Raineteau O. Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner. The Journal of Neuroscience 2012, 2012(32):18009-18017.
23. Power R.A., Muthén B., Henigsberg N., Placentino A., Mendlewicz J., Maier W., et al. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder. Journal of Psychiatric Research 2012, 46(10):1333-1338.
24. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
25. Quitkin F.M., Rabkin J.G., Ross D., Stewart J.W. Identification of true drug response to antidepressants. Use of pattern analysis. Archives of General Psychiatry 1984, 41:782-786.
26. Ramanan V.K., Kim S., Holohan K., Shen L., Nho K., Risacher S.L., et al. Alzheimer's disease neuroimaging initiative (ADNI). Genome-wide pathway analysis of memory impairment in the Alzheimer's disease neuroimaging initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging and Behavior 2012, 6:634-648.
27. Ripke S., Wray N.R., Lewis C.M., Hamilton S.P., Weissman M.M., Breen G., et al. Amega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry 2012, [accessed 03.04.12]. 10.1038/mp.2012.21.
28. Rush A.J., Trivedi M., Fava M. Depression. IV: STAR*D treatment trial for depression. American Journal of Psychiatry 2003, 160:237.
29. Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 2003, 54:573-583.
30. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
31. Tansey K.E., Guipponi M., Hu X., Domenici E., Lewis G., Malafosse A., et al. Heritability of antidepressant response estimated from genome-wide data. Genome Medicine 2012, 4(6):52.
32. Tansey K.E., Guipponi M., Perroud N., Bondolfi G., Domenici E., Evans D., et al. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLOS Medicine 2012, 9(10):e1001326. [accessed 07.12.12]. 10.1371/journal.pmed.1001326.
33. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 2006, 163:28-40. STAR*D Study Team.
34. Uher R., Farmer A., Maier W., Rietschel M., Hauser J., Marusic A., et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychological Medicine 2008, 38(2):289-300.
35. Uher R., Maier W., Hauser J., Marusic A., Schmael C., Mors O., et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 2009, 194(3):252-259.
36. Uher R., Mors O., Rietschel M., Rajewska-Rager A., Petrovic A., Zobel A., et al. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the genome-based therapeutic drugs for depression (GENDEP) study. Journal of Clinical Psychiatry 2011, 72(11):1478-1484.
37. Uher R., Muthén B., Souery D., Mors O., Jaracz J., Placentino A., et al. Trajectories of change in depression severity during treatment with antidepressants. Psychological Medicine 2010, 40(8):1367-1377.
38. Uher R., Perroud N., Ng M.Y., Hauser J., Henigsberg N., Maier W., et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. American Journal of Psychiatry 2010, 167:555-564.
39. Uher R., Tansey K.E., Rietschel M., Henigsberg N., Maier W., Mors O., et al. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. American Journal of Psychiatry 2013, 170(2):207-217.
40. Weiss L.A., Arking D.E., Gene Discovery Project of Johns Hopkins & the Autism Consortium, Daly M.J., Chakravarti A. Agenome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461(7265):802-808.
41. Zhang K., Cui S., Chang S., Zhang L., Wang J. i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Research 2010, 38:W90-W95.